PARALLELS BETWEEN THE HEMODYNAMIC PROFILE AND BIOMARKERS ACTIVITY IN DIFFERENT FORMS OF ACUTE HEART FAILURE IN THE EARLY PERIOD AFTER AORTOCORONARY BYPASS

Goal: to study the rates of central hemodynamics and clinical progress and to evaluate the activity of biomarkers of myocarditis overload and damage in patients with isolated reduction of systolic function of right or left ventricle in early period after aortocoronary bypass. 25 patients were enrolled into the study (14 men, 11 women, average age 58 ± 7 years), admitted to the intensive care department after aortocoronary bypass with artificial circulation and in need of inotropic therapy. Rates of central hemodymanics were monitored with the help of PiCCO system and VoLEF additional module. Blood was collected to assess the NT-proBNP level in 1 and 24 hours from the admission to the intensive care department, and tropinin I level - in 24 hours. It has been found out that the acute heart failure in early period after aortoconorary bypass was associated with isolated systolic dysfunction of right ventricle in 40% of cases, with left ventricle in 32% and in 28% it was of bi-ventricular nature. Failure of right ventricle requires a continuous rehabilitation period and bigger activity pf NT-proBNR compared to the left ventricle failure while the troponin I level does not confidently differ for these groups.

1. Lomivorotov V.V., Fominsky E.V., Efremov S.M. et al. Impact of solution of NaCl (7.2%) and hydroxyethylated starch (6%) in the proportion of 200/0.5 on system inflammatory response when performing surgery for myocardium revasculation using artificial circulation. Vestnik Anasteziol. i Reanimatol., 2013, no. 2, pp. 24¬30. (In Russ.)

2. Rubinchik V.E., Bautin A.E., Laletin D.A. et al. Osobennosti klinicheskogo techeniya i intensivnoy terapii v rannem posleoperatsionnom periode u patsientov, perenesshikh transplantatsiyu serdtsa. [Specifics of clinical progress and intensive care in early postoperative period in patients after heart transplantation]. Sb. materialov XIII s'ezda Federatsii anesteziologov i reanimatologov Rossii. [Abstract Book of the XIII Congress of Russian Anesthesiologists and Emergency Physicians Federation]. 2012, pp. 101¬102. (In Russ.)

3. Kharlamova E.V. Natriyureticheskiye peptidy V-typa i centralnaya gemodinamika vo vremya kardiokhirurgicheskiye operatsii u bolnykh ishemicheskoy boleznyu serdtsa. Diss. kand. med. nauk. [Natriuretic peptyds of B type and central hemodynamics during cardiosurgery in patients with coronary heart disease]. Cand. Diss., Research Institute of Transplantology and Bioartificial Organs, 2008, pp. 14-15. (In Russ.)

4. Shmyrev V.A., Ponomarev D.N., Lomivorotov V.V. et al. System inflammatory response when using distant ischemic pre¬conditioning in cardiosurgical patients. Vestnik Anasteziol. i Reanimatol., 2014, no. 3, pp. 10¬17. (In Russ.)

5. Alehagen U., Svensson E., Dahlström U. Natriuretic peptide biomarkers as information indicators in elderly patients with possible heart failure followed over six years: a head¬to¬head comparison of four cardiac natriuretic peptides. Cardiac Failure. 2007, vol. 13, pp. 452¬461.

6. Bettencourt P., Januzzi J.L. Amino¬Terminal Pro¬B¬Type natriuretic peptide testing for inpatient monitoring and treatment guidance of acute destabilized heart failure. Amer. J. Cardiol. 2008, vol. 101 (Suppl. 3A), pp. 67¬71.

7. Global atlas on cardiovascular disease prevention and control. Geneva: World Health Organization; 2011.

8. Maisel A., Mueller C., Kirkwood A.J. et al. State of the art: Using natriuretic peptide levels in clinical practice. Eur. J. Heart Fail. 2008, vol. 10, pp. 824¬839.

9. McClure S.J., Gall S., Schechter C.B. et al. Percutaneous coronary revascularization reduces plasma N¬terminal pro¬B¬type natriuretic peptide BNP and coronary artery disease in hemodialysis patients concentration in stable coronary artery disease. Cardiology. 2007, vol. 49, pp. 2394¬2397.

10. McDonagh T.A., Holmer S., Raymond I. et al. NT¬proBNP and the diagnosis of heart failure: a pooled analysis of three European epidemiological studies. Eur. J. Heart Failure. 2004, vol. 6, pp. 269¬273.

11. Mebazaa A., Pitsis A., Rudiger А. Clinical review: practical recommendations on the management of perioperative heart failure in cardiac surgery. Crit. Care. 2010, vol. 14, pp. 201.

12. Norbert F., Voelkel N.F., Robert A. et al. Right ventricular function and failure: Report of a National Heart, Lung, and Blood Institute Working Group on cellular and molecular mechanisms of right heart failure. Circulation. 2006, vol. 114, pp. 1883¬1891.

13. Schuuring M.J., Bolmers P.P., Mulder B.J. Right ventricular function declines after cardiac surgery in adult patients with congenital heart disease. Int. J. Cardiovasc Imaging. 2012, vol. 28, no. 4, pp. 755¬762.

14. Thomas G.D.S., Mathier M., Semigran M.J. et al. Preserved right ventricular ejection fraction predicts exercise capacity and survival in advanced heart failure. J. Amer. College of Cardiology. 1995, vol. 25, pp. 1143¬1153.

15. Wagner F. Monitoring and management of right ventricular function following cardiac transplantation. Transplantationsmedizin. 2011, vol. 23, pp. 169¬176.